You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Acute GVHD

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

GVHD,Acute Trial (OSSM-001)

Withdrawn
  • GVHD,Acute
  • OSSM-001
  • (no location specified)
Dec 21, 2022

Acute GVHD Trial (MTX, Corticosteroid)

Not yet recruiting
  • Acute Graft Versus Host Disease
  • (no location specified)
Jun 26, 2023

Graft Vs Host Disease Trial in Vandoeuvre Les Nancy (Uvadex, Steroids)

Not yet recruiting
  • Graft Vs Host Disease
  • Vandoeuvre Les Nancy, France
    CHRU de Nancy
Nov 10, 2023

GVHD, Postbiotics, Butyrate Trial in Seoul (sodium butyrate)

Recruiting
  • Graft Versus Host Disease
  • +2 more
  • sodium butyrate
  • Seoul, Korea, Republic of
    Soonchunhyang University Seoul Hospital
Apr 11, 2023

GVHD Trial (Grafalon, Thymoglobulin)

Not yet recruiting
  • GVHD
  • (no location specified)
Oct 9, 2023

Acute GVHD, Steroid Refractory GVHD Trial in Columbus (BRD4 Inhibitor PLX51107)

Recruiting
  • Acute Graft Versus Host Disease
  • Steroid Refractory Graft Versus Host Disease
  • BRD4 Inhibitor PLX51107
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Mar 24, 2022

GVHD Trial in Cleveland (Allogeneic mesenchymal stromal cells (MSCs), Extracorporeal photopheresis (ECP))

Not yet recruiting
  • Graft Versus Host Disease
  • Allogeneic mesenchymal stromal cells (MSCs)
  • Extracorporeal photopheresis (ECP)
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center, Case Comprehensiv
Nov 14, 2022

Hematologic Malignancy Trial in Milwaukee (Tacrolimus, Methotrexate, Tocilizumab)

Active, not recruiting
  • Hematologic Malignancy
  • Milwaukee, Wisconsin
    Froedtert Hospital
Jan 31, 2023

Dendritic Cells in Acute or Chronic Skin Graft Versus Host

Recruiting
  • Acute Graft-versus-host Disease
  • +3 more
  • Skin punch biopsy
  • Peripheral blood draw
  • Saint Louis, Missouri
    Washington University School of Medicine
May 31, 2022

GVHD Trial in Durham (Prochymal®)

Completed
  • Graft Versus Host Disease
  • Durham, North Carolina
    Duke University
Jan 14, 2022

Gastro-Intestinal Acute GVHD (GI-aGVHD) Trial in Cleveland (Fecal Microbiota Transplantation (FMT))

Withdrawn
  • Gastro-Intestinal Acute Graft Versus Host Disease (GI-aGVHD)
  • Fecal Microbiota Transplantation (FMT)
  • Cleveland, Ohio
    Case Medical Center, University Hospitals Seidman Cancer Center,
Jul 1, 2022

Analysis of Intestinal Defensin Expression in Acute GVHD

Active, not recruiting
  • GVHD,Acute
  • +2 more
    • Freiburg, Baden-Württemberg, Germany
      Medical Center University of Freiburg
    Nov 3, 2021

    Acute-graft-versus-host Disease Trial in Minneapolis (Ruxolitinib 10 MG Oral Tablet, hCG, Corticosteroids)

    Not yet recruiting
    • Acute-graft-versus-host Disease
    • Ruxolitinib 10 MG Oral Tablet
    • +2 more
    • Minneapolis, Minnesota
      Masonic Cancer Center at University of Minnesota
    Nov 2, 2022

    Allogeneic Disease, GVHD,Acute, Graft Failure Trial (WJ-MSC infusion)

    Not yet recruiting
    • Allogeneic Disease
    • +2 more
    • WJ-MSC infusion
    • (no location specified)
    May 4, 2023

    aGVHD, Stem Cell Transplant Complications Trial in Beijing (Ruxolitinib, Corticosteroid)

    Recruiting
    • aGVHD
    • Stem Cell Transplant Complications
    • Beijing, Beijing, China
      Chinese PLA General Hospital
    May 23, 2022

    Acute Graft Versus Host Disease

    Not yet recruiting
    • GVHD,Acute
    • blood sample
    • Detroit, Michigan
      Henry Ford Health System
    Jan 30, 2023

    Acute GVHD (Gvhd) Grade, Hematopoietic Cell Transplantation, Fecal Microbiota Transplant Trial in Boston (Fecal Microbiota

    Recruiting
    • Acute Graft-Versus-Host Disease (Gvhd) Grade
    • +2 more
    • Fecal Microbiota Transplant
    • Boston, Massachusetts
      Massachusetts General Hospital
    Sep 29, 2021

    GVHD Trial in Hackensack (Telmisartan)

    Active, not recruiting
    • GVHD
    • Hackensack, New Jersey
      Hackensack University Medical Center
    Sep 2, 2022

    Cytomegalovirus Infections Trial (Cytotect®CP)

    Recruiting
    • Cytomegalovirus Infections
    • Lille, France
      Hop Claude Huriez Chu Lille
    Nov 8, 2022

    Acute Leukemia, Hematologic and Lymphocytic Disorder, Myelodysplastic Syndrome Trial in Duarte (Fludarabine, Itacitinib Adipate,

    Active, not recruiting
    • Acute Leukemia
    • +4 more
    • Duarte, California
      City of Hope Medical Center
    Jan 4, 2023

    Acute Lymphoblastic Leukemia (ALL) in Partial Remission, Acute Lymphoblastic Leukemia (ALL) in Complete Remission, Acute Myeloid

    Recruiting
    • Acute Lymphoblastic Leukemia (ALL) in Partial Remission
    • +2 more
    • Riyadh, Saudi Arabia
      King Faisal Specialist Hospital & Research Center
    Apr 4, 2022

    GVHD Trial in United States (Abatacept)

    Recruiting
    • Graft Versus Host Disease
    • Birmingham, Alabama
    • +8 more
    Mar 16, 2022

    GVHD, GVHD, Acute-graft-versus-host Disease Trial in Canada, United States (Itolizumab, EQ001 Placebo)

    Recruiting
    • Graft Versus Host Disease
    • +4 more
    • Itolizumab
    • EQ001 Placebo
    • Duarte, California
    • +5 more
    Jul 5, 2022

    Leukemia, Lymphoma, Non-Hodgkin, Hematologic Diseases Trial in Stanford (Sirolimus, MMF, BCNU)

    Completed
    • Leukemia
    • +3 more
    • Stanford, California
      Stanford University School of Medicine
    Sep 16, 2021

    GVHD,Acute, GVHD, Chronic Trial in Salamanca (Physical exercise)

    Recruiting
    • GVHD,Acute
    • GVHD, Chronic
    • Physical exercise
    • Salamanca, Spain
      University of Salamanca
    May 27, 2022